Literature DB >> 11141336

Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains.

M Feili-Hariri1, P A Morel.   

Abstract

We compared BM-derived DC from NOD with DC from non-diabetes-prone strains. NOD myeloid progenitors cultured in GM or GM + IL-4 yielded lower numbers of DC than similar cultures from other strains. NOD GM + IL-4 DC produced lower amounts of IL-12 p70 following CD40 ligation or LPS stimulation in the presence of IFN-gamma than DC from other strains, although similar levels of IL-6 and NO were produced by all strains. The low amounts of IL-12 p70 produced by GM + IL-4 DC are despite a more mature DC phenotype observed in NOD mice. The low DC number could diminish the ability of DC to stimulate immunoregulatory T cells. Furthermore, the differentiation/maturation of DC from myeloid progenitors is altered, reflecting disorders in the function of these cells in NOD BM. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11141336     DOI: 10.1006/clim.2000.4959

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  27 in total

Review 1.  Dendritic cells, T cell tolerance and therapy of adverse immune reactions.

Authors:  P A Morel; M Feili-Hariri; P T Coates; A W Thomson
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

Review 2.  Dendritic cell immunotherapy for autoimmune diabetes.

Authors:  Maryam Feili-Hariri; Rafael R Flores; A Cecilia Vasquez; Penelope A Morel
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

4.  OdDHL inhibits T cell subset differentiation and delays diabetes onset in NOD mice.

Authors:  Wendy Gaisford; David I Pritchard; Anne Cooke
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

5.  Designing the optimal vaccine: the importance of cytokines and dendritic cells.

Authors:  Penelope A Morel; Michael S Turner
Journal:  Open Vaccine J       Date:  2010

6.  Gene expression analysis of dendritic cells that prevent diabetes in NOD mice: analysis of chemokines and costimulatory molecules.

Authors:  Penelope A Morel; Mangala Srinivas; Michael S Turner; Patrizia Fuschiotti; Rajan Munshi; Ivet Bahar; Maryam Feili-Hariri; Eric T Ahrens
Journal:  J Leukoc Biol       Date:  2011-05-31       Impact factor: 4.962

7.  Dendritic cell-targeted pancreatic beta-cell antigen leads to conversion of self-reactive CD4(+) T cells into regulatory T cells and promotes immunotolerance in NOD mice.

Authors:  Cathleen Petzold; Julia Riewaldt; Tina Koenig; Sonja Schallenberg; Karsten Kretschmer
Journal:  Rev Diabet Stud       Date:  2010-05-10

8.  Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.

Authors:  Thomas Enzler; Silke Gillessen; Michael Dougan; James P Allison; Donna Neuberg; Darryl A Oble; Martin Mihm; Glenn Dranoff
Journal:  Blood       Date:  2007-05-04       Impact factor: 22.113

9.  Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice.

Authors:  A C Vasquez; M Feili-Hariri; R J Tan; P A Morel
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

10.  Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.

Authors:  Arunika Mukhopadhaya; Tadashi Hanafusa; Irene Jarchum; Yi-Guang Chen; Yoshiko Iwai; David V Serreze; Ralph M Steinman; Kristin V Tarbell; Teresa P DiLorenzo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.